Submit your email to push it up the queue
Merck Canada Inc., a subsidiary of Merck & Co., Inc., is a leading player in the pharmaceutical and biotechnology industry, headquartered in Canada. Established in 1891, the company has a rich history of innovation and commitment to improving health outcomes across the nation and beyond. With major operational regions spanning Ontario and Quebec, Merck Canada focuses on developing prescription medicines, vaccines, biologic therapies, and animal health products. Renowned for its core offerings in oncology, vaccines, and infectious diseases, Merck Canada distinguishes itself through its dedication to research and development, driving advancements that address unmet medical needs. The company has achieved significant milestones, including the introduction of groundbreaking therapies that have transformed patient care. As a trusted name in the healthcare sector, Merck Canada continues to uphold its reputation for excellence and leadership in the market.
How does Merck Canada Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Merck Canada Inc.'s score of 72 is higher than 84% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Merck Canada Inc. currently does not have specific carbon emissions data available for the most recent year, as indicated by the absence of emissions figures. The company is a current subsidiary of Merck & Co., Inc., which may influence its climate commitments and initiatives. While no direct emissions data is reported, Merck Canada Inc. inherits its climate commitments and reduction targets from its parent company, Merck & Co., Inc. This includes participation in various sustainability initiatives such as the Science Based Targets initiative (SBTi) and the Carbon Disclosure Project (CDP), both of which are cascaded from the parent organization. Merck & Co., Inc. has set ambitious targets to reduce greenhouse gas emissions across its operations, which may include Scope 1, 2, and 3 emissions. However, specific reduction targets or achievements for Merck Canada Inc. are not detailed in the available information. In summary, while Merck Canada Inc. does not provide specific emissions data or reduction targets, it aligns with the broader climate commitments of its parent company, Merck & Co., Inc., reflecting a commitment to sustainability and climate action within the pharmaceutical industry.
Access structured emissions data, company-specific emission factors, and source documents
2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Scope 1 | - | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
Scope 2 | - | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
Scope 3 | 5,760,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 |
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Merck Canada Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.